Form 4: Treace Medical Concepts CEO John T. Treace Reports Changes in Beneficial Ownership

John T. Treace, CEO of Treace Medical Concepts, reports disposition of common stock to cover tax obligations related to restricted stock units.

Summary

• On March 8, 2025, John T. Treace disposed of 2,063 shares of common stock to cover tax obligations, resulting in a beneficial ownership of 6,794,127 shares.
• On March 10, 2025, Treace disposed of 5,021 shares of common stock for tax obligations, leaving him with 6,789,106 shares.
• Treace also indirectly owns shares through his spouse and trusts, but disclaims beneficial ownership of those shares.
• The report includes holdings of 429,067 and 408,448 restricted stock units.
• Lisa Taylor, as Attorney-in-fact for John Treace, signed the report on March 11, 2025.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions by an insider, primarily related to tax obligations. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, like the CEO, when there are changes in their beneficial ownership of the company's securities. It provides transparency to the market regarding the transactions of company executives.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in the CEO's holdings, but the impact is likely minimal as the sales are for tax obligations.

Key Dates